This is a community-generated profile. If you would like to claim it, please .
DiscoverStartupsZymeworksZymeworks Funding Rounds, Valuation & Investors
Zymeworks company logo
Zymeworks
Optimizing protein therapeutics for diseases201-500 Employees
View 1 job

Zymeworks Funding

$0
66 rounds
Zymeworks is active in the following markets / industries: biotechnology. The company has secured funding across 6 rounds and is valued at $0. Their most recent funding was raised on January 8, 2016.

Funding Rounds

A
$61500000
Series AJan 2016$0 valuation
Avatar for Lumira Capital
Avatar for Perceptive Advisors
Avatar for Merlin Nexus
+1
Press
Zymeworks Announces $61.5 Million Financing to Support the Clinical Development of its Pipeline of Azymetric™ Antibody Therapeutics
U
$15000000
UnknownJan 2014
U
$11000000
UnknownSep 2012
D
$8100000
Series DSep 2011
Avatar for CTI Capital
C
$3500000
Series CJun 2009
Avatar for CTI Capital
S
$1300000
SeedMar 2008

Investors of Zymeworks

Teralys Capital
VC Firm
Fonds de Solidarite FTQ
VC Firm • Québec City
Avatar for Fonds de Solidarite FTQ
Eli Lilly
VC Firm • Indianapolis
Avatar for Eli Lilly
Discovers, develops, and manufactures pharmaceutical products
Merlin Nexus
VC Firm • New York City
Avatar for Merlin Nexus
Rounds
A
Eli Lilly & Co
VC Firm
Rounds
A
Celgene
VC Firm • Summit
Avatar for Celgene
Rounds
A
Lumira Capital
VC Firm • Toronto
Avatar for Lumira Capital
Rounds
A
Perceptive Advisors
VC Firm • New York City
Avatar for Perceptive Advisors
Rounds
A
CTI Capital
VC Firm
Avatar for CTI Capital
Rounds
D
C
Back to People
Onwards to Jobs